Literature DB >> 21903860

The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption.

David J Mellis1, Cecile Itzstein, Miep H Helfrich, Julie C Crockett.   

Abstract

Osteoclasts are the specialised cells that resorb bone matrix and are important both for the growth and shaping of bones throughout development as well as during the process of bone remodelling that occurs throughout life to maintain a healthy skeleton. Osteoclast formation, function and survival are tightly regulated by a network of signalling pathways, many of which have been identified through the study of rare monogenic diseases, knockout mouse models and animal strains carrying naturally occurring mutations in key molecules. In this review, we describe the processes of osteoclast formation, activation and function and discuss the major transcription factors and signalling pathways (including those that control the cytoskeletal rearrangements) that are important at each stage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903860     DOI: 10.1530/JOE-11-0212

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  40 in total

1.  Effect of corticision on orthodontic tooth movement in a rat model as assessed by RNA sequencing.

Authors:  Qihui Gu; Shuyu Guo; Dongyue Wang; Tingting Zhou; Lin Wang; Zhendong Wang; Junqing Ma
Journal:  J Mol Histol       Date:  2017-04-13       Impact factor: 2.611

Review 2.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

3.  Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.

Authors:  Ethan M Lotz; Michael B Berger; Barbara D Boyan; Zvi Schwartz
Journal:  Bone       Date:  2020-02-03       Impact factor: 4.398

4.  Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.

Authors:  Antonius L J J Bronckers; Donacian M Lyaruu; Theodore J Bervoets; Juan F Medina; Pamela DenBesten; Johan Richter; Vincent Everts
Journal:  Bone       Date:  2012-01-08       Impact factor: 4.398

5.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

Review 6.  Advances in the regulation of osteoclasts and osteoclast functions.

Authors:  B F Boyce
Journal:  J Dent Res       Date:  2013-08-01       Impact factor: 6.116

7.  Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Authors:  Adel Ersek; Ke Xu; Aristotelis Antonopoulos; Terry D Butters; Ana Espirito Santo; Youridies Vattakuzhi; Lynn M Williams; Katerina Goudevenou; Lynett Danks; Andrew Freidin; Emmanouil Spanoudakis; Simon Parry; Maria Papaioannou; Evdoxia Hatjiharissi; Aristeidis Chaidos; Dominic S Alonzi; Gabriele Twigg; Ming Hu; Raymond A Dwek; Stuart M Haslam; Irene Roberts; Anne Dell; Amin Rahemtulla; Nicole J Horwood; Anastasios Karadimitris
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 8.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

9.  Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.

Authors:  Tsuguno Yamaguchi; Alexandru Movila; Shinsuke Kataoka; Wichaya Wisitrasameewong; Montserrat Ruiz Torruella; Michiaki Murakoshi; Shinya Murakami; Toshihisa Kawai
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 10.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.